Lipa

Minto, Australia Founded: 1995 • Age: 31 yrs
Dietary supplements and OTC pharmaceuticals are contract-manufactured.

About Lipa

Lipa is a company based in Minto (Australia) founded in 1995. Lipa offers products and services including Tablets, Hard Capsules, Soft Capsules, Liquids, and Powders. Lipa operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

  • Headquarter Minto, Australia
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website lipa.com.au
  • Social LinkedIn
  • Legal Name Lipa Pharmaceuticals Limited
Key Metrics

Products & Services of Lipa

Lipa offers a comprehensive portfolio of products and services, including Tablets, Hard Capsules, Soft Capsules, Liquids, and Powders.

Tablets
Pharmaceutical Products

Manufactured for over-the-counter or prescription medications.

Hard Capsules
Pharmaceutical Products

Encapsulate sensitive ingredients for easier ingestion.

Soft Capsules
Pharmaceutical Products

Used for oils and liquids in therapeutic applications.

Liquids
Pharmaceutical Products

Include aqueous liquids and gels for various uses.

Powders
Pharmaceutical Products

Produced with precise filling for supplements.

Creams and Gels
Pharmaceutical Products

Formulated for targeted dermatological treatments.

Probiotics
Pharmaceutical Products

Ensure viability for digestive health support.

Private Label
Pharmaceutical Products

Ready-made products for client branding.

Funding Insights of Lipa

  • Total Rounds 2
  • Last Round Grant β€” $118,907
  • First Round $25,444

    (Jun 2014)

  • Investors Count 1

All 2 funding rounds of Lipa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2019$118,907Grant––
Jun 2014$25,444Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Lipa

Lipa has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Lipa

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Lipa

17 people are tracked at Lipa (7 in leadership, 10 in team).

NameRoleGroup
Rob Tanna
CEOLeadership
Robert Roach
Chief Manufacturing OfficerLeadership
Suzanne Casanova
Director Of Planning And Supply ChainLeadership
Wim Huizer
Chief of QualityLeadership
Karen Grigg
Chief People Culture And Safety OfficerLeadership
Fleur Sinclair
Operations Business PartnerLeadership
George G.
Director Of QualityLeadership
Annemarie West
Human Resources OfficerTeam
Kamran Alam
QC ManagerTeam
Con Tzouroutis
Validation ManagerTeam
Toufic Elmir
Quality & Manufacturing Lead - ERP ProjectTeam
M.D. Alamgir Sarkar
Senior QC Chemist (raw Material)Team
Samir Zende
Research & Development LeadTeam
Ling Jiang
Product Development SpecialistTeam
Rhianna Lakeman
Procurement OfficerTeam
Marie Kitiona
Recruitment CoordinatorTeam
Ceazar Tanzilur Rahman
Project Delivery And Continous Improvement ManagerTeam
Premium access

Complete people profiles for Lipa

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Lipa

3 dated milestones of Lipa across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lipa is founded.
  2. Funding First funding round of $25K.
  3. Funding Latest funding round, Grant, of $119K.

Competitors of Lipa

Lipa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India––
Company offering a suite of R&D and manufacturing services for small molecules and generics
recipharm.com1995Jordbro, Sweden–1,083
Pharmaceutical development and manufacturing services are offered contractually.
unither-pharma.com1993Paris, France––
Contract development and manufacturing organization for proprietary and generic drugs
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
corerxpharma.com2006Clearwater, United States$15M–
CDMO with a focus on early phase drug product development
windlas.com2001Gurugram, India$12.96M1,264
Biopharma regulatory affairs, quality control, and strategy services are provided.
zambon.com1906Bresso, Italy––
APIs and finished drugs are developed and manufactured in pharmaceuticals.
aenova-group.com2008Starnberg, Germany––
CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided.
leukocare.com2003Munich, Germany$17.5M70
Proprietary stabilizing solutions for biologics formulations are developed.
Premium access

Detailed competitors of Lipa

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lipa

The website of Lipa (lipa.com.au) receives about 6.5K visits a month and ranks #2,944,886 among all websites worldwide, #3,928 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    6.5K

    ▼ 12.8% vs previous month

  • Unique visitors
    3.2K

    per month

  • Global rank
    #2,944,886

    among all websites

  • Category rank
    #3,928

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Lipa. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
britannia-pharm.co.uk
100%
2K#7,663,681View details
acrux.com.au
100%
3.7K#7,741,592View details
vandapharma.com
97%
44.7K#942,850View details
austpharma.com.au
95%
2.4K#7,513,906View details
maynepharma.com
82%
18.6K#918,677View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Lipa

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Lipa

Lipa Wins Again
Cmocro β€’ 7 years ago
Premium access

Complete news archive for Lipa

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Lipa

10 companies that operate in the same segment as Lipa (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lipa

Lipa was founded in 1995 and raised its 1st funding round 19 years after it was founded.

Lipa is headquartered in Minto, Australia. It is registered at Minto, New South Wales, Australia.

Founded in 1995, Lipa operates as a contract manufacturer based in Minto, Australia. Dietary supplements and over-the-counter pharmaceutical products are produced through its facilities. Services encompass formulation, production, and packaging for clients in the health and wellness sector. Operations adhere to regulatory standards for quality and safety in the pharmaceutical industry. The companys domain, lipa.com.au, supports client inquiries and partnerships.

Lipa's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Lipa offers Tablets, Hard Capsules, Soft Capsules, Liquids, and 4 more products and services.

Lipa has 1 investor. Key investors include European Union.

Lipa operates through Lipa Pharmaceuticals Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available